Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 14

Results For "mRNA"

221 News Found

Evonik now offers enteric protected ready to fill capsules EUDRACAP in IPEC-GMP quality
News | July 15, 2022

Evonik now offers enteric protected ready to fill capsules EUDRACAP in IPEC-GMP quality

Supports development and commercialization of complex oral drugs using sensitive molecules, including biologicals


Capnopharm to acquire operational assets of Capnomed
News | July 10, 2022

Capnopharm to acquire operational assets of Capnomed

Capnomed successfully introduced the medical device Capnopen, the gold standard of laparoscopic nebulizers.


Jubilant HollisterStier announces CAD 100 mn for Montreal facility
News | July 01, 2022

Jubilant HollisterStier announces CAD 100 mn for Montreal facility

The Government of Quebec, through its agent Investissement Quebec, is granting a loan of CAD 25 million


Pfizer and BioNTech inks new agreement with US Government to provide additional doses of COVID-19 vaccine
News | June 30, 2022

Pfizer and BioNTech inks new agreement with US Government to provide additional doses of COVID-19 vaccine

105 million 30 µg, 10 µg and 3 µg doses to be delivered into Q4 2022, with an option for the U.S. Government to purchase up to 195 million additional doses


Pfizer and BioNTech announce Omicron-adapted COVID-19 vaccine candidates demonstrate high immune response against omicron
News | June 27, 2022

Pfizer and BioNTech announce Omicron-adapted COVID-19 vaccine candidates demonstrate high immune response against omicron

Both vaccine candidates demonstrated a favorable safety and tolerability profile similar to the Pfizer-BioNTech COVID-19 Vaccine


Merck KGaA doubles HPAPI production capacity in Wisconsin
News | June 24, 2022

Merck KGaA doubles HPAPI production capacity in Wisconsin

This new €59 million, 70,000 square foot facility, officially opened today, brings 50 new jobs to the area


Eurocine Vaccines expands portfolio with a therapeutic HSV-2 vaccine candidate
News | June 15, 2022

Eurocine Vaccines expands portfolio with a therapeutic HSV-2 vaccine candidate

Redbiotec has a right to royalties on Eurocine Vaccines´ net sales of an approved HSV-2 vaccine, should such sales arise.


Sanofi-GSK next-gen COVID-19 booster delivers strong immune response against main variants
News | June 14, 2022

Sanofi-GSK next-gen COVID-19 booster delivers strong immune response against main variants

Next-generation booster vaccine candidate demonstrates potential to protect against COVID-19 variants of concern, including Omicron BA.1 and BA.2, with a favorable safety and tolerability profile


Moderna to become marketing authorization holder in Japan for Spikevax
News | June 01, 2022

Moderna to become marketing authorization holder in Japan for Spikevax

Companies concluded memorandum of understanding that Takeda will continue to provide distribution support for the Moderna COVID-19 vaccines for a transitional period


Jubilant HollisterStier enters into agreement of $149.6 mn with US Govt to expand critical vaccine manufacturing capacity
News | June 01, 2022

Jubilant HollisterStier enters into agreement of $149.6 mn with US Govt to expand critical vaccine manufacturing capacity

This agreement is in addition to the $92 million filling line expansion announced in November 2021